Carigent Therapeutics

Company Information

Company Name
Carigent Therapeutics
Address
5 Science Park
Suite 13
New Haven, CT, 06511 1966
Phone
1 203-752-0808
URL
n/a
DUNS
605510093
Number of Employees
5
Hubzone Owned

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$454,802.00
3
Chart code to be here

Award List

  1. Long Circulating Targeted Nanoparticles for non-Hodgkin's Lymphoma Treatment

    Amount: $153,437.00

    DESCRIPTION (provided by applicant): The long-term objectives of this proposal Long-Circulating Targeted Nanoparticles for Non-Hodgkin's Lymphoma Treatment are to (1) develop a novel, surface-modifi ...

    SBIR Phase I 2007 Department of Health and Human Services
  2. Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma

    Amount: $204,344.00

    DESCRIPTION (provided by applicant): The long-term clinical objective of this proposal Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma is the development of a novel th ...

    SBIR Phase I 2008 Department of Health and Human Services
  3. SBIR PHASE I: Tumor-Targeting Particles for the Delivery of Paclitaxel Against Ovarian Cancer

    Amount: $97,021.00

    PARS Summary This Small Business Innovation Research (SBIR) Phase I research project aims to develop paclitaxel-loaded nano particles with avidin modified surfaces for the targeting of the drug to cel ...

    SBIR Phase I 2008 National Science Foundation

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government